San Diego, CA (PRWEB) September 5, 2007
Salugen, Inc. (http://www.salugen.com), a leading personalized health and wellness company, named Ms. Lonna Williams as Chief Operating Officer and Senior Vice President of Sales and Marketing, underscoring the company's commitment to the upcoming launches of its product portfolio and attracting senior level management talent.
"Moving beyond the pilot phase of our business towards full-scale commercialization requires hands-on leadership of an executive who has the skill set to introduce new medical technologies. Salugen will benefit greatly from Lonna's commercial experience, expertise gained as an officer of a publicly-traded company, and passion for improving people's lives," states Salugen CEO Brian Meshkin. "Lonna's unique experience, having launched PSA as a screening test for detecting prostate cancer, the first DNA probe test cleared for use in the US, some pharmacogenetic tests and many other new technologies, is an ideal fit for Salugen's unconventional model of personalized medicine."
In her new role, Lonna will oversee the commercial operations and drive the growth and development of the key brands, as well as contribute to corporate and business development. Additionally, Lonna will oversee commercial partner relationships and develop strategic opportunities for the company.
Most recently, Lonna Williams was Chief Marketing and Clinical Officer of Viking Systems, a publicly-traded medical device firm in San Diego. Ms. Williams was formerly President of MedicalMarketSolutions, a health care product consulting firm. She has 20 years of experience in marketing, sales and business development in medical diagnostics, devices and pharmaceuticals and has held executive level positions in several public and privately held companies. Ms. Williams has brought over 25 new products to market and commercialized four novel technologies. She has held senior management positions at Johnson and Johnson's Ortho Clinical Diagnostics, Hybritech/Eli Lilly, GenProbe, Inc., Quidel Corporation and LifePoint, Inc. She has been involved in corporate acquisitions and technology licensing and has created and implemented business plans, integration and commercialization plans supporting the acquisitions. She graduated from the University of Southern Colorado.
Salugen, Inc., a leading personalized health and wellness company, engages in the discovery, development and commercialization of patent-protected genetic tests and companion DNA-customized therapeutics worldwide. With over 30 years of research conducted on the genetic causes and pharmacology of many healthcare concerns, Salugen is a pioneer and leader in delivering personalized medicine. Currently, the Company commercializes nutrigenomic technologies where genetic analysis guides the formulation and delivery of nutritional solutions that are customized to the individual. The company has headquarters in San Diego, CA, with its high-complexity CLIA-certified laboratory services in Los Angeles, CA. For additional information about the company, please visit http://www.salugen.com.
# # #